Introduction
The use of measures such as journal's impact factor (IF) and h-index to quantify the scientific creditability of research and researchers had been gaining worldwide acceptability. Increasingly these metrics are being used to assess the scientific output of different countries to a particular specialty [1] [2] [3] [4] . The worldwide ranking of universities had drawn substantial attention and it is expected that the global ranking of medical specialty research will generate more interest. The objective of this study was to identify the top 50 countries in the world in clinical neurology research and to use their data to assess the impact of a number of countryspecific characteristics on scientific productivity in clinical neurology.
Methods
SCImago Journal & Country Rank (SCR) [5] is a portal that integrates journal and country scientific statistics developed from Scopus database.
The site provides lists of worldwide ranking based on 6 productivity indicators which are: total documents, total cites, h-index, citable documents, self-cites and citations per document. The findings vary according to the searched subject area, category, region and year. The SCR site [5] was searched on 1st November 2015 using the parameters "medicine" for subject area, "clinical neurology" for subject category, "1996-2014" for year and "all" for region. The site was also searched for "clinical neurology journals" and found to include 335 international journals that covered the range of clinical neuroscience specialties. Using the site we obtained a list of the top 50 countries in the world based on their total documents in clinical neurology. Information connected to 5 country-specific characteristics were gathered. These were: population size from the worldometer web site [6] , gross domestic product at purchasing power parity (GDP) per capita from the International Monetary Fund database [7] , percentage of GDP spent on research and development (R & D) from the World Bank web site [8] , number of universities in the world top 500 from the Shanghai ranking web site [9] and the number of clinical neurology journals enlisted in SCR [5] . Furthermore, figures pertaining to the 6 productivity indicators provided in SCR were collected for each country. The data for the 5 country-specific characteristics and the 6 productivity indicators were correlated by calculating Pearson correlation coefficient (r) using Social Sciences Statistics [10] with significance being reached when P was less than 0.05. Contents lists available at ScienceDirect eNeurologicalSci j o u r n a l h o m e p a g e : h t t p : / / e e s . e l s e v i e r . c o m / e n s c i /
Results
The range (median) for each of the 5 country-specific characteristics was; population size: 2,069,000-1,347,000,000 (27,409,500), GDP Table 1 shows the top 50 countries in clinical neurology research ranked by their total documents with data for 4 country-specific characteristics (GDP per capita, percentage of GDP spent on R & D, number of universities in the world top 500 and the number of clinical neurology journals enlisted in SCR [5] ) and 3 productivity indices (total documents, h-index and citations per document). Table 2 summarizes the correlation results between the 5 country-specific characteristics and the 6 productivity indicators.
Discussion
Bibliometric indicators are established tools used in the assessment of research performance in various disciplines. The data pool in this study was large compared to other published studies (335 journals over a 19-year period) [1] [2] [3] [4] . Furthermore, the number of country-specific characteristics (5) and scientific productivity indicators (6) assessed in this study was higher than in other studies in the literature [1] [2] [3] [4] . We observed that population size did not correlate significantly with any of the 6 productivity indicators. This indicates that population size has no significant impact on clinical neurology research output, which is contrary to reports from foot and ankle research [1] , arthroscopy [2] and rheumatology [3] .
The impact of high GDP on productivity had been reported as significant in a number of publications [1] [2] [3] . Conversely the impact of GDP per capita on research outcomes had been described as non-significant in two publications [4, 11] . In this study, the GDP per capita was associated with a significant impact on clinical neurology research based on 3 out of the 6 productivity indicators (total cites, h-index and citations per document). In addition, the percentage of GDP spent on R & D was associated with a significant impact on the scientific output in the specialty using 4 out of the 6 indicators (total documents, h-index, citable documents and citations per document). Halpennny et al. [12] reported that the percentage of GDP spent on R & D positively correlated with the number of publications in high-ranking radiology journals. Meo et al. [4] reported a significant correlation between spending on R & D and pharmacological sciences research based on 2 out of 4 productivity indicators (citations per document and h-index). They also reported a significant correlation between the total number of universities and journals indexed in the Institute of Scientific Information (ISI) with research publications according to 3 out of 4 indicators (total documents, citable documents and h-index) [4] . Meo and Usmani [11] also reported that spending on R & D, number of universities, indexed journals, high technology exports and number of patents had a positive correlation with the number of published documents by European countries in various science and social subjects. In addition, Choung and Hwang [13] described a positive interaction between scientific and technological activities. They reported that universities perform a crucial role in expanding the number of publications and that their research activities were important in sustaining the progress of industrial technologies. In this study, we found that the number of universities in the world top 500 and the number of clinical neurology journals enlisted in SCR [5] were associated with a significant impact on the scientific productivity based on all the 6 indicators. The findings are not surprising as the ranking of the top 500 universities in the world is partially defined by the number of publications. Furthermore, as SCR was the source of data for the 6 productivity indices, it is therefore not unexpected that the number of clinical neurology journals listed in that website correlated with scientific productivity of the country. Data relating to the percentage of publications in the SCR journals that originated from the host country would have been be informative but this was not provided in the web site. Nevertheless, the results highlight the importance for a country to produce high impact factor journals and to have top ranking universities that can advance clinical neurology research nationally or globally through a collaborative approach.
There are a number of limitations to this study. The study was dependent on the accuracy of the web site search engine SCR. It is possible that there were errors particularly with multi-national publications. The study was also reliant on the correctness of the web sites used for the country-specific characteristics.
Conclusions
Based on data relating to the top 50 countries in clinical neurology research, the number of universities in the world top 500 and the number of clinical neurology journals listed in the SCR [5] appear to have a strong impact on clinical neurology productivity from a country. The GDP per capita and spending on R & D appear to have a moderate impact on productivity that is influenced by the indicator used. Furthermore, population size appears to have no significant impact on productivity in clinical neurology research.
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